The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
Open accessAbstract
Glioblastoma (GBM) is distinguished by a high degree of intratumoral heterogeneity, which extends to the pattern of expression and amplification of receptor tyrosine kinases(RTKs). Although most GBMs harbor RTK amplifications, clinical trials of small-molecule inhibitors targeting individual RTKs have been disappointing to date. Activation of multiple RTKs within individual GBMs provides a theoretical mechanism of resistance; however, the spectrum of functional RTK dependence among tumor cell subpopulations in actual tumors is unknown. We investigated the pattern of heterogeneity of RTK amplification and functional RTK dependence in GBM tumor cell subpopulations. Analysis of The Cancer Genome Atlas GBM dataset identified 34 of 463 cases showing independent focal amplification of two or more RTKs, most commonly platelet-derived growth factor receptor α (PDGFRA) and epidermal growth factor receptor (EGFR). Dual-color fluorescence in situ hybridization was performed on eight samples with EGFR and PDGFRA amplification, revealing distinct tumor cell subpopulations amplified for only one RTK; in all cases these predominated over cells amplified for both. Cell lines derived from coamplified tumors exhibited genotype selection under RTK-targeted ligand stimulation or pharmacologic inhibition in vitro. Simultaneous inhibition of both EGFR and PDGFR was necessary for abrogation of PI3 kinase pathway activity in the mixed population. DNA sequencing of isolated subpopulations establishes a common clonal origin consistent with late or ongoing divergence of RTK genotype. This phenomenon is especially common among tumors with PDGFRA amplification: overall, 43% of PDGFRA-amplified GBM were found to have amplification of EGFR or the hepatocyte growth factor receptor gene (MET) as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Self-citationTumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316 · cited 2×
“Discussion Gene amplification is the most common mechanism by which RTKs are altered in GBM (1, 3).”
BackgroundSelf-citationTumour microvesicles contain retrotransposon elements and amplified oncogene sequences
Balaj, L., Lessard, R., Dai, L., Cho, Y.-J., Pomeroy, S. L., Breakefield, X. O., & Skog, J. (2011) · Nature Communications · doi:10.1038/ncomms1180 · Cited by 1,187
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., et al. (2007) · Science · doi:10.1126/science.1142946 · Cited by 938 · cited 2×
“In fact, concurrent phosphorylation of multiple RTKs has been demonstrated in GBM and has been shown to mediate resistance to single-RTK inhibition through “RTK switching” in cell lines (11).”
BackgroundResultSelf-citationA mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7727 · Cited by 936
Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
Bondy, M. L., Scheurer, M. E., Malmer, B., Barnholtz-Sloan, J. S., Davis, F. G., Il'yasova, D., Kruchko, C., McCarthy, B. J., Rajaraman, P., Schwartzbaum, J. A., et al. (2008) · Cancer · doi:10.1002/cncr.23741 · Cited by 932
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2818 · Cited by 763
Self-citationInda, M.-D.-M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D. W. Y., Vandenberg, S., Brennan, C., Johns, T. G., Bachoo, R., Hadwiger, P., et al. (2010) · Genes & Development · doi:10.1101/gad.1890510 · Cited by 543
Self-citationBrennan, C., Momota, H., Hambardzumyan, D., Ozawa, T., Tandon, A., Pedraza, A., & Holland, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007752 · Cited by 534
Self-citationInferring tumor progression from genomic heterogeneity
Navin, N., Krasnitz, A., Rodgers, L., Cook, K., Meth, J., Kendall, J., Riggs, M., Eberling, Y., Troge, J., Grubor, V., et al. (2010) · Genome Research · doi:10.1101/gr.099622.109 · Cited by 524
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing
Campbell, P. J., Pleasance, E. D., Stephens, P. J., Dicks, E., Rance, R., Goodhead, I., Follows, G. A., Green, A. R., Futreal, P. A., & Stratton, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801523105 · Cited by 365
Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.
Bigner, S. H., Humphrey, P. A., Wong, A. J., Vogelstein, B., Mark, J., Friedman, H. S., & Bigner, D. D. (1990) · PubMed · Cited by 331
Giannini, C., Sarkaria, J. N., Saito, A., Uhm, J. H., Galanis, E., Carlson, B. L., Schroeder, M. A., & James, C. D. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000821 · Cited by 326
Raizer, J. J., Abrey, L. E., Lassman, A. B., Chang, S. M., Lamborn, K. R., Kuhn, J. G., Yung, W. K. A., Gilbert, M. R., Aldape, K. A., Wen, P. Y., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop015 · Cited by 299
Raymond, E., Brandes, A. A., Dittrich, C., Fumoleau, P., Coudert, B., Clement, P. M. J., Frenay, M., Rampling, R., Stupp, R., Kros, J. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.9235 · Cited by 227
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas
Ozawa, T., Brennan, C. W., Wang, L., Squatrito, M., Sasayama, T., Nakada, M., Huse, J. T., Pedraza, A., Utsuki, S., Yasui, Y., et al. (2010) · Genes & Development · doi:10.1101/gad.1972310 · Cited by 217
Self-citationContrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR
Pandita, A., Aldape, K. D., Zadeh, G., Guha, A., & James, C. D. (2004) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10300 · Cited by 211
Hegi, M. E., Diserens, A.-C., Bady, P., Kamoshima, Y., Kouwenhoven, M. C. M., Delorenzi, M., Lambiv, W. L., Hamou, M.-F., Matter, M. S., Koch, A., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0048 · Cited by 194
Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies
Hamer, P. C. D. W. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop068 · Cited by 166
Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma
Bigner, S. H., & Vogelstein, B. (1990) · Brain Pathology · doi:10.1111/j.1750-3639.1990.tb00633.x · Cited by 158
Al-Mayhani, T. M. F., Ball, S. L. R., Zhao, J., Fawcett, J. W., Ichimura, K., Collins, P. V., & Watts, C. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.07.022 · Cited by 157
Martinho, O., Longatto‐Filho, A., Lambros, M. B., Martins, A. M., Pinheiro, C. M., da Silva, A. S. L., Pardal, F., de Amorim, J. A., Mackay, A. G., Milanezi, F., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605225 · Cited by 146
A mathematical framework to determine the temporal sequence of somatic genetic events in cancer
Attolini, C. S., Cheng, Y.-K., Beroukhim, R., Getz, G. A., Abdel-Wahab, O. I., Levine, R. L., Mellinghoff, I. K., & Michor, F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009117107 · Cited by 140
Feedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development
Wiedemeyer, R., Brennan, C., Heffernan, T. P., Xiao, Y., Mahoney, J. E., Protopopov, A. I., Zheng, H., Bignell, G. R., Furnari, F. B., Cavenee, W. K., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.010 · Cited by 126
Self-citationLópez‐Ginés, C., Gil‐Benso, R., Ferrer-Luna, R., Benito, R., Serna, E., Gonzalez-Darder, J. M., Quilis-Quesada, V., Monleón, D., Celda, B., & Cerdá‐Nicolás, M. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.62 · Cited by 123
Okada, Y., Hurwitz, E. E., Esposito, J. M., et al. (2003) · PubMed · Cited by 118
Brain Tumor Microvesicles: Insights into Intercellular Communication in the Nervous System
van der Vos, K. E., Balaj, L., Skog, J., & Breakefield, X. O. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9697-y · Cited by 112
SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans
Liu, K.-W., Feng, H., Bachoo, R. M., Kazlauskas, A., Smith, E. M., Symes, K., Hamilton, R. L., Nagane, M., Nishikawa, R., Hu, B., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43690 · Cited by 95
Krishnan, S., Brown, P. D., Ballman, K. V., Fiveash, J. B., Uhm, J. H., Giannini, C., Jaeckle, K. A., Geoffroy, F. J., Nabors, B., & Buckner, J. C. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.018 · Cited by 90
Fomchenko, E. I., Dougherty, J. D., Helmy, K. Y., Katz, A. M., Pietras, A., Brennan, C., Huse, J. T., Milosevic, A., & Holland, E. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020605 · Cited by 77
Self-citationKimmel, M., & Axelrod, D. E. (1990) · Genetics · doi:10.1093/genetics/125.3.633 · Cited by 69
Growth factor profiles of human gliomas
van der Valk, P., Lindeman, J., & Kamphorst, W. (1997) · Annals of Oncology · doi:10.1023/a:1008265905505 · Cited by 56
Paulsson, J., Lindh, M. B., Jarvius, M., Puputti, M., Nistér, M., Nupponen, N. N., Paulus, W., Söderberg, O., Dresemann, G. P., von Deimling, A., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25528 · Cited by 54
Haberler, C., Gelpí, E., Marosi, C., Rössler, K., Birner, P., Budka, H., & Hainfellner, J. A. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-4570-9 · Cited by 50
Hasselbalch, B., Eriksen, J. G., Broholm, H., Christensen, I. J., Grunnet, K., Horsman, M. R., Poulsen, H. S., Stockhausen, M., & Lassen, U. (2010) · Apmis · doi:10.1111/j.1600-0463.2010.02631.x · Cited by 45
Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies
Witusik‐Perkowska, M., Rieske, P., Hułas-Bigoszewska, K., Zakrzewska, M., Stawski, R. S., Kulczycka-Wojdala, D., Bieńkowski, M., Stoczyńska-Fidelus, E., Grešner, S. M., Piaskowski, S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0352-0 · Cited by 44
Cited by
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
“4%, 14/33), as did the majority of MET-altered tumors (3/4), reflecting a pattern of intratumoral heterogeneity that has been previously documented by in situ hybridization (Snuderl et al., 2011; Szerlip et al., 2012).”
BackgroundSelf-citationCSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Self-citationThe causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Johnson, B. E., Mazor, T., Hong, C., Barnes, M., Aihara, K., McLean, C. Y., Fouse, S. D., Yamamoto, S., Ueda, H., Tatsuno, K., et al. (2014) · Science · doi:10.1126/science.1239947 · Cited by 1,362
“Many solid tumors, including glioblastoma (GBM) display intratumoral heterogeneity (17, 18).”
Metadata
- Authors
- Szerlip, N. J., Pedraza, A., Chakravarty, D., Azim, M., McGuire, J., Fang, Y., Ozawa, T., Holland, E. C., Huse, J. T., Jhanwar, S., Leversha, M. A., Mikkelsen, T., & Brennan, C. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-02-08
- Volume
- 109
- Issue
- 8
- Pages
- 3041-3046
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2061760261
- Cited by
- 538
- References
- 39
- FWCI
- 24.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.